6.
Reid BJ, et al. Predictors of progression of cancer in Barrett’s esophagus: baseline histology and flow cytometry identify low and high-risk patient subsets. Am J Gastroenterol. 2000;95:1669–76.
7.
Morrow EH, Oelschlager BK. Barrett’s esophagus. CDS Surgery online resource; 2012.
8.
Oelschlager BK, et al. Clinical and pathologic response of Barrett’s esophagus to laparoscopic anti-reflux surgery. Ann Surg. 2003;238:458–66.
9.
Wassenaar E, Oelschlager BK. Effect of medical and surgical treatment of Barrett’s metaplasia. World J Gastroenterol. 2010;16(30):3773–9.CrossRef
10.
Oelschlager BK, Pellegrini CA. Laparoscopic treatment of Barrett’s esophagus. Adv Surg. 2004;38:1–12.
11.
Milind R, Attwood SE. Natural history of Barrett’s esophagus. World J Gastroenterol. 2012;18(27):3483–91.CrossRef
12.
Chang EY, et al. The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett esophagus, a systematic review. Ann Surg. 2007;246:11–21.CrossRef
13.
Parrilla P, et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg. 2003;237:291–8.
14.
Rees JRE, Lao-Sirieix P, Wong A, Fitzgerald RC. Treatment for Barrett’s oesophagus. Cochrane Database Syst Rev. 2010(1):CD004060. doi: 10.1002/14651858.CD004060.pub2. Review.
15.
Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology. 2011;140:e18–52.
16.
Bennett C, et al. Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012;143:336–46.CrossRef
17.
Pech O, Behrens A, May A, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut. 2008;57:1200–6.CrossRef
18.
Dunbar KB, Spechler SJ. The risk of lymph node metastases in patients with high grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol. 2012;107(6):850–63.CrossRef
19.
Leers JM, et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg. 2011;253:271–8.CrossRef
20.
Collard JM. High-grade dysplasia in Barrett’s esophagus. Chest Surg Clin N Am. 2002;12:77–92.CrossRef
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
